You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 11,020,448


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,020,448
Title:Methods comprising desmopressin
Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
Inventor(s): Klein; Bjarke Mirner (Frederiksberg, DK), Norgaard; Jens Peter (Frederiksberg, DK)
Assignee: FERRING B.V. (Hoofddorp, NL)
Application Number:16/162,453
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using US Patent 11,020,448 as an Example

Introduction to Patent Analysis

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. Here, we will use U.S. Patent 11,020,448 as an example to delve into the key aspects of patent analysis.

Understanding Patent Scope

What is Patent Scope?

Patent scope refers to the breadth and depth of protection granted by a patent. It is defined by the claims of the patent, which are the legal descriptions of the invention for which protection is sought[3].

Identifying the Patent

To start, you need to identify the patent in question. For U.S. Patent 11,020,448, you can use the USPTO's Patent Public Search tool or other online databases like Google Patents or the European Patent Office's Espacenet.

Reading the Patent Document

Title and Abstract

The title and abstract provide a brief overview of the invention. This is where you get the first glimpse of what the patent is about.

Background of the Invention

This section explains the context and prior art related to the invention. It helps in understanding the problem the invention solves and how it differs from existing solutions.

Summary of the Invention

This section provides a concise description of the invention, highlighting its key features and advantages.

Detailed Description of the Invention

Here, you will find a detailed explanation of the invention, including drawings, diagrams, and examples. This section is crucial for understanding the technical aspects of the invention.

Analyzing the Claims

Independent and Dependent Claims

Patent claims are divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

  • Independent Claim Length and Count: Research suggests that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims at publication are often associated with a higher probability of grant and a shorter examination process[3].

Claim Language

The language used in the claims is critical. It must be clear, concise, and specific to avoid ambiguity and potential litigation.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is often a point of contention in patent litigation, as the interpretation can significantly affect the scope of the patent.

Prior Art and Patent Landscape

Searching Prior Art

To understand the patent landscape, you need to search for prior art. This involves using resources like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as the European Patent Office's Espacenet and the World Intellectual Property Organization's PATENTSCOPE[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating IP5 Offices, providing a single point of access to up-to-date citation data. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

Patent Family and Global Dossier

Patent Family

The patent family includes all related applications filed at participating IP Offices. Using the Global Dossier service, you can see the dossier, classification, and citation data for these applications, as well as Office Action Indicators to identify applications with office actions[1].

Office Actions and Examination History

Patent Examination Data System (PEDS)

The PEDS allows you to search, view, and download bibliographic data for all publicly available patent applications. This includes examination history and office actions, which can provide insights into the patent's validity and the examiner's perspective[1].

Statistical Analysis

Patent Maintenance Payments and Forward Citations

Metrics such as patent maintenance payments and forward citations can indicate the scope and impact of a patent. Patents with narrower claims at publication tend to have higher maintenance payments and more forward citations, suggesting their importance and influence in the field[3].

Practical Steps for Analyzing a Patent

Step 1: Identify the Patent

Use online databases to locate the patent document.

Step 2: Read the Patent Document

Carefully read the title, abstract, background, summary, and detailed description.

Step 3: Analyze the Claims

Focus on independent and dependent claims, and consider metrics like claim length and count.

Step 4: Search Prior Art

Use various patent search tools to identify relevant prior art.

Step 5: Examine the Patent Family

Utilize the Global Dossier to understand the patent family and global citations.

Step 6: Review Office Actions

Access the PEDS to view examination history and office actions.

Example: Analyzing U.S. Patent 11,020,448

  • Title and Abstract: Start by reading the title and abstract to understand the invention's purpose and key features.
  • Claims Analysis: Identify the independent and dependent claims. Analyze the language and scope of these claims.
  • Prior Art Search: Conduct a thorough search using the USPTO's Patent Public Search and other international databases to ensure the invention is novel and non-obvious.
  • Global Dossier: Use the Global Dossier to see the patent family and any related applications or citations.
  • Office Actions: Review the examination history and any office actions through PEDS.

Key Takeaways

  • Clear Claims: Ensure the claims are clear, concise, and specific to avoid ambiguity.
  • Prior Art: Thoroughly search prior art to validate the novelty and non-obviousness of the invention.
  • Global Perspective: Use tools like the Global Dossier to understand the global patent landscape.
  • Statistical Analysis: Consider metrics like claim length, count, maintenance payments, and forward citations to gauge the patent's scope and impact.

FAQs

Q1: How do I search for a U.S. patent? You can search for a U.S. patent using the USPTO's Patent Public Search tool, Google Patents, or other international patent databases like Espacenet.

Q2: What is the importance of claim construction in patent analysis? Claim construction is crucial as it determines the scope of the patent. Ambiguous claims can lead to litigation and affect the patent's enforceability.

Q3: How can I access the examination history of a patent? You can access the examination history and office actions through the Patent Examination Data System (PEDS) provided by the USPTO.

Q4: What is the Global Dossier, and how does it help in patent analysis? The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices. It helps in understanding the patent family, citations, and office actions globally.

Q5: Why is prior art search important in patent analysis? Prior art search is essential to ensure the novelty and non-obviousness of the invention. It helps in validating the patent's scope and avoiding potential infringement issues.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents
  5. Unified Patents Portal - US-20070032410-A1: https://portal.unifiedpatents.com/patents/patent/US-20070032410-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,020,448

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 DISCN Yes No 11,020,448 ⤷  Subscribe TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS, COMPRISING MONITORING A PATIENT'S SERUM SODIUM CONCENTRATION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,020,448

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2712622 ⤷  Subscribe PA2017001 Lithuania ⤷  Subscribe
European Patent Office 2712622 ⤷  Subscribe 122017000006 Germany ⤷  Subscribe
European Patent Office 2712622 ⤷  Subscribe LUC00015 Luxembourg ⤷  Subscribe
European Patent Office 3225249 ⤷  Subscribe 300983 Netherlands ⤷  Subscribe
European Patent Office 3225249 ⤷  Subscribe CA 2019 00023 Denmark ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.